What is the recommended treatment for an acute gout flare?

Treatment of Acute Gout Flare

For an acute gout flare, treat with corticosteroids, NSAIDs, or colchicine—corticosteroids should be considered first-line in patients without contraindications due to superior safety profile and lower cost. 1

First-Line Treatment Options

All three medication classes are equally effective at reducing pain in acute gout, supported by high-quality evidence 1. Your choice depends on patient-specific contraindications and cost considerations:

Corticosteroids (Preferred First-Line)

• Dosing: Prednisolone 35 mg daily for 5 days 1
• Advantages: Generally safer than NSAIDs, lowest cost, as effective as NSAIDs with fewer adverse effects
• Contraindications: Systemic fungal infections, uncontrolled diabetes
• Cautions: Short-term use may cause mood changes, hyperglycemia, fluid retention 1

NSAIDs (Alternative First-Line)

• Any NSAID is acceptable—indomethacin has no proven superiority over naproxen or ibuprofen despite traditional preference 1
• Contraindications: Renal disease, heart failure, cirrhosis, history of GI bleeding
• Adverse effects: Dyspepsia, GI perforation/ulcers/bleeding 1

Colchicine (Alternative First-Line)

• Dosing: Use low-dose only: 1.2 mg followed by 0.6 mg one hour later (strong recommendation) 1
  • This low-dose regimen is as effective as high-dose (1.2 mg followed by 0.6 mg hourly for 6 hours) but with significantly fewer GI side effects 1
• Disadvantages: More expensive than corticosteroids or NSAIDs 1
• Contraindications: Renal or hepatic impairment in patients using potent CYP3A4 inhibitors or P-glycoprotein inhibitors 1
• Adverse effects: Diarrhea, nausea, vomiting, abdominal cramps 1

Critical Decision Algorithm

1. No contraindications to any agent? → Start corticosteroids (safest, cheapest)
2. Diabetes or infection concerns? → Use NSAIDs (if kidneys/heart/liver normal) or colchicine
3. Renal disease, heart failure, or cirrhosis? → Use corticosteroids or colchicine (check drug interactions for colchicine)
4. On CYP3A4 inhibitors with renal/hepatic disease? → Use corticosteroids or NSAIDs

Important Considerations During Acute Flare

Do not delay starting urate-lowering therapy (ULT) if indicated—the 2020 ACR guideline conditionally recommends starting ULT during an acute flare rather than waiting for resolution 2. This represents a shift from older practice patterns.

Common Pitfalls to Avoid

• Don't use high-dose colchicine: The traditional high-dose regimen (0.6 mg hourly) causes unnecessary GI toxicity without additional benefit 1
• Don't assume indomethacin is superior: No evidence supports this traditional preference over other NSAIDs 1
• Don't overlook corticosteroids: Despite being highly effective and safe for short-term use, they're often underutilized 1
• Don't forget drug interactions with colchicine: Particularly dangerous with CYP3A4 inhibitors (macrolides, azole antifungals) in patients with renal/hepatic impairment 1

After Acute Flare Resolution

Once the acute flare is controlled, assess need for long-term ULT based on frequency of attacks (≥2 per year warrants consideration) and discuss prophylaxis strategy during ULT initiation 1. The 2020 ACR strongly recommends continuing anti-inflammatory prophylaxis for 3-6 months when starting ULT 2, as flares are common after stopping prophylaxis 3.